Breaking News Headlines Today | Ground News

See every side of every news story

inovio.com image

News from inovio.com

inovio.com’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Is inovio.com credible or reliable? Our Factuality score answers both of those questions. When it comes to inovio.com, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about inovio.com

Where is inovio.com located?inovio.com's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top inovio.com News

Vivid Seats to Report Third Quarter 2025 Financial Results

Vivid Seats to Report Third Quarter 2025 Financial Results

80% Left coverage: 15 sources

CHICAGO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (NASDAQ:SEAT) (“Vivid Seats”), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, will…See the Story

INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference

Plymouth Meeting · Plymouth Meeting

INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference

54% Center coverage: 13 sources

PLYMOUTH MEETING, Pa., Oct. 23, 2025 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that it will participate…See the Story

First-in-Human Study of DNA Antibody Replicas Generate Efficient and Long-Lasting Biologic Production of Human Antiviral Antibodies

Philadelphia, Pennsylvania · Philadelphia

First-in-Human Study of DNA Antibody Replicas Generate Efficient and Long-Lasting Biologic Production of Human Antiviral Antibodies

A multidisciplinary team of scientists led by The Wistar Institute, including Perelman School of Medicine at the University of Pennsylvania, AstraZeneca and Inovio Pharmaceuticals, published today in Nature Medicine a breakthrough in biologic antibody production that happens directly in human subjects in this encouraging first clinical trial of its kind.See the Story

Breaking News Topics Related to inovio.com